Tri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
Tri-Coast Pharmacy is recalling 17 vials of TriMix injection because the agency could not ensure the products were sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in an injectable medication, which poses a risk of harm even without reported injuries.
Plain-English summary
Tri-Coast Pharmacy is recalling 17 vials of TriMix, a compounded medication containing Alprostadil, Phentolamine, and Papaverine. The recall is being conducted because there is a lack of assurance that the sterile products were properly sterilized.
The recall includes all sterile products compounded between May 17, 2016, and November 17, 2016. Specific lot codes affected include 07112016B, 09222016H, 10252016F, 09232016S, 09072016E, and 11032016F. The products were distributed nationwide.
Consumers and healthcare providers should check their inventory for these specific lot codes and dates. If the product is found, it should be returned to the pharmacy or the manufacturer for disposal or credit.
The recalled product
- Product
- TriMix, Alprostadil/Phentolamine/Papaverine 40mcg/2mg/30mg/mL, (1 ML). Compounded by Tri-Coast Pharmacy
- Manufacturer
- Tri-Coast Pharmacy
- Category
- Drug — Compounded Injectable
- Affected units
- 17
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- 09222016H (11/06/2016)
- 10252016F (12/09/2016)
- 09232016S (11/06/2016)
- 09072016E (09/29/2016)
- 11032016F (12/09/2016).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 80 recalled by Tri-Coast Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 80 products in this recall →Related recalls
Same manufacturer · Tri-Coast Pharmacy
See all →- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Sermorelin Forte Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls TriMix Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls BiMix Phentolamine/Papaverine Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereTri-Coast Pharmacy Recalls Quad Mix Sterile Compounded Drug
FDA (Drugs) · 2017-01-11
Same hazard · sterility
See all →- SevereFDA Recalls Testosterone Cypionate Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-28
- SevereHeparin Sodium Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-28
- SevereHouston Rx LLC Recalls Tirzepatide/Niacinamide Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-21
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereTri-Mix Injections Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-06-12
- SeverePharm D Solutions Recalls Trimix Injection Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- SevereTrimix Injectable Vials Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-03-23
- HighPharm D Solutions Recalls Trimix Powder Due to Sterility Concerns
FDA (Drugs) · 2018-11-07
- HighMartin Avenue Pharmacy Recalls Tri-mix Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-11-05
- SeverePharm D Solutions Recalls Tri-Mix Injectable Due to Sterility Concerns
FDA (Drugs) · 2018-11-07